Comment
doi: 10.1016/S0140-6736(04)17117-1.
Parkinson's disease and dementia with Lewy bodies: a difference in dose?
Affiliations
- PMID: 15451205
- DOI: 10.1016/S0140-6736(04)17117-1
Item in Clipboard
Comment
Parkinson's disease and dementia with Lewy bodies: a difference in dose?
Lancet.
2004.
No abstract available
Comment on
-
Alpha-synuclein locus duplication as a cause of familial Parkinson's disease.Lancet. 2004 Sep 25-Oct 1;364(9440):1167-9. doi: 10.1016/S0140-6736(04)17103-1. Lancet. 2004. PMID: 15451224
-
Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease.Lancet. 2004 Sep 25-Oct 1;364(9440):1169-71. doi: 10.1016/S0140-6736(04)17104-3. Lancet. 2004. PMID: 15451225
Similar articles
-
Alpha-synuclein locus duplication as a cause of familial Parkinson's disease.Lancet. 2004 Sep 25-Oct 1;364(9440):1167-9. doi: 10.1016/S0140-6736(04)17103-1. Lancet. 2004. PMID: 15451224
-
Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease.Lancet. 2004 Sep 25-Oct 1;364(9440):1169-71. doi: 10.1016/S0140-6736(04)17104-3. Lancet. 2004. PMID: 15451225
-
Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.J Neurochem. 2004 Oct;91(2):451-61. doi: 10.1111/j.1471-4159.2004.02728.x. J Neurochem. 2004. PMID: 15447678
-
Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants.Ann N Y Acad Sci. 2000;920:42-5. doi: 10.1111/j.1749-6632.2000.tb06903.x. Ann N Y Acad Sci. 2000. PMID: 11193175 Review. No abstract available.
-
Structure/function of alpha-synuclein in health and disease: rational development of animal models for Parkinson's and related diseases.J Neurochem. 2002 Aug;82(3):449-57. doi: 10.1046/j.1471-4159.2002.01020.x. J Neurochem. 2002. PMID: 12153470 Review. No abstract available.
Cited by
-
Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates.J Neurosci. 2006 Sep 27;26(39):10068-78. doi: 10.1523/JNEUROSCI.0896-06.2006. J Neurosci. 2006. PMID: 17005870 Free PMC article.
-
What causes cell death in Parkinson's disease?Ann Neurol. 2008 Dec;64 Suppl 2(0 2):S3-15. doi: 10.1002/ana.21573. Ann Neurol. 2008. PMID: 19127586 Free PMC article. Review.
-
Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells.J Biol Chem. 2008 Aug 29;283(35):23542-56. doi: 10.1074/jbc.M801992200. Epub 2008 Jun 19. J Biol Chem. 2008. PMID: 18566453 Free PMC article.
-
The Evolution of Genetics: Alzheimer's and Parkinson's Diseases.Neuron. 2016 Jun 15;90(6):1154-1163. doi: 10.1016/j.neuron.2016.05.040. Neuron. 2016. PMID: 27311081 Free PMC article. Review.
-
α-Synuclein Strains: Does Amyloid Conformation Explain the Heterogeneity of Synucleinopathies?Biomolecules. 2021 Jun 23;11(7):931. doi: 10.3390/biom11070931. Biomolecules. 2021. PMID: 34201558 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
